How many stem-cell trials for Alzheimer's Disease are recruiting right now?
Right now 10 of 41 records (24%) carry recruiting status; the rest are completed, finished enrolling or stopped. Snapshot 2026-08-29.
Who these studies will actually take
Enrolment usually requires biomarker confirmation — amyloid PET or CSF — plus a caregiver who attends visits and a cognitive score inside a defined band. That last criterion excludes both very early and advanced patients, which is why families often find they qualify for nothing despite a large registry list.
The studies currently enrolling
| Study | Phase | Status | Planned n | Lead sponsor | Start |
|---|---|---|---|---|---|
| NCT02795052 — Neurologic Stem Cell Treatment Study | n/a | Recruiting | 500 | MD Stem Cells | 2016-06 |
| NCT07367815 — Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease | Phase 1, Phase 2 | Recruiting | 9 | University Hospital, Toulouse | 2026-05-07 |
| NCT05667649 — Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease | Phase 1 | Recruiting | 18 | Regeneration Biomedical, Inc. | 2023-08-14 |
| NCT04684602 — Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions | Phase 1, Phase 2 | Recruiting | 5,000 | Thomas Advanced Medical LLC | 2020-07-09 |
| NCT07512362 — Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease. | Phase 2 | Recruiting | 10 | Bernard (Barry) Baumel | 2026-05-15 |
| NCT06775964 — Stem Cell Therapy for Early Alzheimer's Disease | Phase 1, Phase 2 | Recruiting | 12 | Paul E Schulz | 2026-03-11 |
| NCT07457125 — The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease | Phase 1, Phase 2 | Recruiting | 33 | Xuanwu Hospital, Beijing | 2026-05-30 |
| NCT00874783 — Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases | n/a | Recruiting | 120 | Hadassah Medical Organization | 2009-04 |
What recruiting does and does not mean
The status field tracks paperwork, not promise. What matters underneath it is the eligibility list, the outcome measures the sponsor committed to, and whether a site near you is actually enrolling, all of which sit on the registry record itself.
Sites sit in 10 countries, led by United States. Travelling for a trial rarely works unless the site has confirmed in writing that it can enrol non-residents and fund the follow-up schedule.
Who is running the studies here
Lead sponsors appearing most often for this condition. Useful for one specific check: whether the entity quoting research at you appears anywhere in it.
- Regeneration Biomedical, Inc. — 3 registered records
- Bernard (Barry) Baumel — 3 registered records
- Medipost Co Ltd. — 3 registered records
- MD Stem Cells — 2 registered records
- Nature Cell Co. Ltd. — 2 registered records
- Xuanwu Hospital, Beijing — 2 registered records
Frequently asked
How many stem-cell trials for Alzheimer's Disease are recruiting right now?
10 of 41 registered records (2026-08-29).
Can I join one of these trials?
Only if you meet the published eligibility criteria and the site confirms capacity. Start from the registry record's contact block, not from a clinic advertisement.
Do trials charge participants?
Participants are not usually billed for the study product. A five-figure invoice attached to a supposed trial place means you are buying a treatment, not joining research.
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.
More on this condition
- Alzheimer's Disease: cell-therapy evidence and registered trials
- How much does stem cell therapy for Alzheimer's Disease cost? (2026)
- Alzheimer's Disease stem cell therapy — your questions answered (2026)
- Alzheimer's Disease: cell-therapy evidence by therapy class
- MSC vs exosomes for Alzheimer's Disease: what the registries show